Collegium Pharmaceutical, Inc.
DE ˙ DB ˙ US19459J1043
26,00 € ↓ -0,80 (-2,99%)
2026-06-03
AKTIENPREIS
SecurityDE:354 / Collegium Pharmaceutical, Inc.
InstitutionNorthern Trust Corp
Latest Disclosed Ownership361,889 shares
Latest Disclosed Value $ 11,967,669
Northern Trust Corp reports 2.34% increase in ownership of 354 / Collegium Pharmaceutical, Inc.

On May 14, 2026 - Northern Trust Corp filed a 13F-HR form disclosing ownership of 361,889 shares of Collegium Pharmaceutical, Inc. (DE:354) valued at $9,988,136 USD as of March 31, 2026. The entity filed a previous 13F-HR on February 17, 2026 disclosing 353,604 shares of Collegium Pharmaceutical, Inc.. This represents a change in shares of 2.34% during the quarter. The current value of the position is $9,409,114 USD.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date		 Effective
Date		Form Security Class ID Avg Price
Paid (Est)		 Reported
Shares		 ΔShares ΔShares
(%)		 Reported
Value
(x1000)		 ΔValue
(%)		 Alloc
(%)		 ΔAlloc ΔAlloc (%) Cost Basis
(x1000)		 Unrealized
Gain/Loss
(x1000)
2026-05-14 2026-03-31 13F COLLEGIUM PHARMACEUTICAL COM 19459J104 361,889 8,285 2.34 11,968 -26.90 0.0016
2026-02-17 2025-12-31 13F COLLEGIUM PHARMACEUTICAL COM 19459J104 353,604 -17,712 -4.77 16,372 26.01 0.0021
2025-11-14 2025-09-30 13F COLLEGIUM PHARMACEUTICAL COM 19459J104 371,316 -9,471 -2.49 12,992 15.39 0.0017
2025-08-13 2025-06-30 13F COLLEGIUM PHARMACEUTICAL COM 19459J104 380,787 -5,177 -1.34 11,260 -2.27 0.0015
2025-05-13 2025-03-31 13F COLLEGIUM PHARMACEUTICAL COM 19459J104 385,964 807 0.21 11,521 4.41 0.0017
2025-02-14 2024-12-31 13F COLLEGIUM PHARMACEUTICAL COM 19459J104 385,157 20,490 5.62 11,035 -21.69 0.0016
2024-11-13 2024-09-30 13F COLLEGIUM PHARMACEUTICAL COM 19459J104 364,667 -4,884 -1.32 14,091 18.41 0.0023
2024-08-14 2024-06-30 13F COLLEGIUM PHARMACEUTICAL COM 19459J104 369,551 -14,488 -3.77 11,900 -20.18 0.0020
2024-05-14 2024-03-31 13F COLLEGIUM PHARMACEUTICAL COM 19459J104 384,039 -16,828 -4.20 14,908 20.83 0.0026
2024-02-13 2023-12-31 13F COLLEGIUM PHARMACEUTICAL COM 19459J104 400,867 -3,153 -0.78 12,339 36.65 0.0022
2023-11-13 2023-09-30 13F COLLEGIUM PHARMACEUTICAL COM 19459J104 404,020 -2,436 -0.60 9,030 3.38 0.0017
2023-08-11 2023-06-30 13F COLLEGIUM PHARMACEUTICAL COM 19459J104 406,456 18,200 4.69 8,735 -6.23 0.0017
2023-05-15 2023-03-31 13F COLLEGIUM PHARMACEUTICAL COM 19459J104 388,256 3,065 0.80 9,314 4.23 0.0018
2023-02-13 2022-12-31 13F COLLEGIUM PHARMACEUTICAL COM 19459J104 385,191 -1,264 -0.33 8,936 44.34 0.0019
2022-11-14 2022-09-30 13F COLLEGIUM PHARMACEUTICAL COM 19459J104 386,455 4,053 1.06 6,191 -8.63 0.0014
2022-08-12 2022-06-30 13F COLLEGIUM PHARMACEUTICAL COM 19459J104 382,402 -10,107 -2.57 6,776 -15.22 0.0015
2022-05-13 2022-03-31 13F COLLEGIUM PHARMACEUTICAL COM 19459J104 392,509 -14,704 -3.61 7,992 5.06 0.0014
2022-02-08 2021-12-31 13F COLLEGIUM PHARMACEUTICAL COM 19459J104 407,213 -25,172 -5.82 7,607 -10.88 0.0012
2021-11-15 2021-09-30 13F COLLEGIUM PHARMACEUTICAL COM 19459J104 432,385 23 0.01 8,536 -16.49 0.0015
2021-08-13 2021-06-30 13F COLLEGIUM PHARMACEUTICAL COM 19459J104 432,362 -6,059 -1.38 10,221 -1.63 0.0018
2021-05-12 2021-03-31 13F COLLEGIUM PHARMACEUTICAL COM 19459J104 438,421 -18,532 -4.06 10,390 13.51 0.0019
2021-02-11 2020-12-31 13F COLLEGIUM PHARMACEUTICAL COM 19459J104 456,953 -19,978 -4.19 9,153 -7.82 0.0018
2020-11-16 2020-09-30 13F COLLEGIUM PHARMACEUTICAL COM 19459J104 476,931 -17,520 -3.54 9,930 14.77 0.0022
2020-08-14 2020-06-30 13F COLLEGIUM PHARMACEUTICAL COM 19459J104 494,451 69,163 16.26 8,652 24.58 0.0020
2020-05-14 2020-03-31 13F COLLEGIUM PHARMACEUTICAL COM 19459J104 425,288 8,311 1.99 6,945 -19.08 0.0020
2020-02-14 2019-12-31 13F COLLEGIUM PHARMACEUTICAL COM 19459J104 416,977 -66,341 -13.73 8,583 54.70 0.0019
2019-11-13 2019-09-30 13F COLLEGIUM PHARMACEUTICAL COM 19459J104 483,318 95,878 24.75 5,548 8.89 0.0013
2019-08-13 2019-06-30 13F COLLEGIUM PHARMACEUTICAL COM 19459J104 387,440 4,201 1.10 5,095 -12.20 0.0012
2019-05-13 2019-03-31 13F COLLEGIUM PHARMACEUTICAL COM 19459J104 383,239 -50 -0.01 5,803 -11.84 0.0014
2019-02-12 2018-12-31 13F COLLEGIUM PHARMACEUTICAL COM 19459J104 383,289 -82,890 -17.78 6,582 -4.21 0.0018
2018-11-14 2018-09-30 13F COLLEGIUM PHARMACEUTICAL COM 19459J104 466,179 -60,320 -11.46 6,871 -45.28 0.0017
2018-09-18 2018-06-30 13F/A-1 COLLEGIUM PHARMACEUTICAL COM 19459J104 526,499 231,463 78.45 12,557 66.58 0.0032
2018-08-14 2018-06-30 13F COLLEGIUM PHARMACEUTICAL COM 19459J104 528,443 233,407 12,604
2018-05-09 2018-03-31 13F COLLEGIUM PHARMACEUTICAL COM 19459J104 295,036 7,553 2.63 7,538 42.04 0.0020
2018-02-14 2017-12-31 13F COLLEGIUM PHARMACEUTICAL COM 19459J104 287,483 12,975 4.73 5,307 84.33 0.0013
2017-11-13 2017-09-30 13F COLLEGIUM PHARMACEUTICAL COM 19459J104 274,508 -3,917 -1.41 2,879 -17.34 0.0008
2017-08-11 2017-06-30 13F COLLEGIUM PHARMACEUTICAL COM 19459J104 278,425 59,579 27.22 3,483 58.17 0.0010
2017-05-12 2017-03-31 13F COLLEGIUM PHARMACEUTICAL COM 19459J104 218,846 3,383 1.57 2,202 -34.37 0.0006
2017-02-13 2016-12-31 13F COLLEGIUM PHARMACEUTICAL COM 19459J104 215,463 38,916 22.04 3,355 -1.32 0.0010
2016-11-09 2016-09-30 13F COLLEGIUM PHARMACEUTICAL COM 19459J104 176,547 5,079 2.96 3,400 67.32 0.0011
2016-08-12 2016-06-30 13F COLLEGIUM PHARMACEUTICAL COM 19459J104 171,468 72,066 72.50 2,032 12.64 0.0007
2016-08-19 2016-03-31 13F/A-1 COLLEGIUM PHARMACEUTICAL COM 19459J104 99,402 15,267 18.15 1,804 -22.01 0.0006
2016-05-13 2016-03-31 13F COLLEGIUM PHARMACEUTICAL COM 19459J104 99,402 1,804
2016-02-12 2015-12-31 13F COLLEGIUM PHARMACEUTICAL COM 19459J104 84,135 16,473 24.35 2,313 54.61 0.0008
2015-11-12 2015-09-30 13F COLLEGIUM PHARMACEUTICAL COM 19459J104 67,662 67,662 1,496 0.0005
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.